HK1150627A1 - Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof - Google Patents

Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof

Info

Publication number
HK1150627A1
HK1150627A1 HK11104573.4A HK11104573A HK1150627A1 HK 1150627 A1 HK1150627 A1 HK 1150627A1 HK 11104573 A HK11104573 A HK 11104573A HK 1150627 A1 HK1150627 A1 HK 1150627A1
Authority
HK
Hong Kong
Prior art keywords
protein sequence
sequence variants
therapeutic uses
plasmids coding
p185neu
Prior art date
Application number
HK11104573.4A
Other languages
English (en)
Inventor
Augusto Amici
Cristina Marchini
Elena Quaglino
Federica Cavallo
Guido Forni
Original Assignee
Augusto Amici
Cristina Marchini
Elena Quaglino
Federica Cavallo
Guido Forni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Augusto Amici, Cristina Marchini, Elena Quaglino, Federica Cavallo, Guido Forni filed Critical Augusto Amici
Publication of HK1150627A1 publication Critical patent/HK1150627A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
HK11104573.4A 2004-10-15 2011-05-09 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof HK1150627A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001965A ITMI20041965A1 (it) 2004-10-15 2004-10-15 "dna codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici"

Publications (1)

Publication Number Publication Date
HK1150627A1 true HK1150627A1 (en) 2012-01-06

Family

ID=35539028

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11104573.4A HK1150627A1 (en) 2004-10-15 2011-05-09 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof

Country Status (22)

Country Link
US (2) US7985582B2 (da)
EP (2) EP1809668A2 (da)
JP (1) JP5597346B2 (da)
KR (1) KR101337706B1 (da)
CN (2) CN101886090B (da)
AT (1) ATE524494T1 (da)
AU (1) AU2005293218B2 (da)
CA (1) CA2583499C (da)
DK (1) DK1939217T3 (da)
ES (1) ES2370540T3 (da)
HK (1) HK1150627A1 (da)
HR (1) HRP20110729T1 (da)
IL (1) IL182510A0 (da)
IT (1) ITMI20041965A1 (da)
NO (1) NO344353B1 (da)
PL (1) PL1939217T3 (da)
PT (1) PT1939217E (da)
RU (1) RU2383620C2 (da)
SG (1) SG148195A1 (da)
SI (1) SI1939217T1 (da)
WO (1) WO2006040660A2 (da)
ZA (1) ZA200703875B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101638440B (zh) * 2008-07-29 2011-10-26 中国人民解放军军事医学科学院基础医学研究所 一种可诱发机体抗肿瘤免疫的异种抗原-Fc融合蛋白及其应用
EP2777711A1 (en) 2013-03-11 2014-09-17 Icon Genetics GmbH Her2/Neu cancer vaccine
US11667960B2 (en) * 2016-04-20 2023-06-06 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and systems for RNA or DNA detection and sequencing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518885A (en) * 1994-04-19 1996-05-21 The United States Of America As Represented By The Department Of Health & Human Services ERBB2 promoter binding protein in neoplastic disease
US7820180B2 (en) * 2004-09-24 2010-10-26 The Trustees Of The University Of Pennsylvania Listeria-based and LLO-based vaccines
US7794729B2 (en) * 1994-11-08 2010-09-14 The Trustees Of The University Of Pennsylvania Methods and compositions for immunotherapy of cancer
CZ20012587A3 (cs) * 1999-01-29 2002-05-15 Corixa Corporation Izolovaný protein, nukleová kyselina, virový vektor, farmaceutický prostředek, izolovaná populace T buněk, způsob posílení imunitní odpovědi, způsob odstranění nádorových buněk, způsob stimulace a/nebo namnoľení T buněk a způsob přípravy fúzního proteinu
US20020177551A1 (en) 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
AU2003286770A1 (en) * 2002-10-30 2004-06-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS
DE10251520A1 (de) * 2002-11-04 2004-05-13 Valeo Wischersysteme Gmbh Adapter für ein Wischblatt
AU2003298786A1 (en) * 2002-11-26 2004-06-18 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
ITMI20031942A1 (it) 2003-10-09 2005-04-10 Indena Spa Dna codificante p185^neu e suoi usi terapeutici

Also Published As

Publication number Publication date
ES2370540T3 (es) 2011-12-19
CN101886090B (zh) 2012-09-26
RU2383620C2 (ru) 2010-03-10
US20110256162A1 (en) 2011-10-20
US8207141B2 (en) 2012-06-26
AU2005293218A1 (en) 2006-04-20
ATE524494T1 (de) 2011-09-15
CN101065399A (zh) 2007-10-31
WO2006040660A2 (en) 2006-04-20
EP1939217B1 (en) 2011-09-14
JP2008516596A (ja) 2008-05-22
JP5597346B2 (ja) 2014-10-01
HRP20110729T1 (hr) 2011-11-30
US20090214577A1 (en) 2009-08-27
IL182510A0 (en) 2007-09-20
PL1939217T3 (pl) 2012-02-29
CA2583499C (en) 2013-12-03
AU2005293218B2 (en) 2011-11-17
ITMI20041965A1 (it) 2005-01-15
NO344353B1 (no) 2019-11-11
CA2583499A1 (en) 2006-04-20
RU2007117894A (ru) 2008-11-20
KR101337706B1 (ko) 2013-12-06
SG148195A1 (en) 2008-12-31
CN101886090A (zh) 2010-11-17
DK1939217T3 (da) 2011-11-21
US7985582B2 (en) 2011-07-26
SI1939217T1 (sl) 2012-01-31
EP1939217A3 (en) 2008-09-03
ZA200703875B (en) 2008-08-27
WO2006040660A3 (en) 2006-06-15
NO20072457L (no) 2007-07-13
PT1939217E (pt) 2011-11-08
KR20070085298A (ko) 2007-08-27
EP1939217A2 (en) 2008-07-02
EP1809668A2 (en) 2007-07-25

Similar Documents

Publication Publication Date Title
DE60028970D1 (de) An her2 bindende peptidverbindungen
WO2005116051A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
HK1101131A1 (en) Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
EP1767546A4 (en) AN ANGIOGENESIS INHIBITING CHIMERIC PROTEIN AND ITS USE
EP1539228A4 (en) NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES
PL2157192T3 (pl) Kompozycje do diagnozowania i terapii chorób związanych z nieprawidłową ekspresją futrin (R-spondin)
PL1972637T3 (pl) Antagoniści selektywni wobec huTNFR1
WO2003016915A8 (en) Tumor specific oligosaccharide sequences and use thereof
WO2005007673A3 (en) Immunogenic peptides
HK1150627A1 (en) Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
IL207012A (en) 28sgp medicinal product and 28sgp accent cancer treatment vaccine
RS20050577A (en) Compositions and methods for treating cancer using igsf9 and liv-1
EP2322209A3 (en) Tumor specific oligosaccharide epitopes and use thereof
WO2004085461A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
WO2003093298A3 (en) Immunogenic peptides
NO20061542L (no) P185neu-Kodende DNA samt terapeutiske anvendelser derav
WO2005037236A3 (en) Novel heat shock protein 20-related polypeptides and uses therefor
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
WO2003022874A1 (en) Antagonist peptides to vegr receptor flt-1
WO2004089980A3 (en) Therapeutic cancer vaccine
AU2003296543A8 (en) Peptides having a high cysteine content